Livongo Health (NASDAQ:LVGO) and MYnd Analytics (NASDAQ:MYND) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations.
Institutional & Insider Ownership
0.5% of MYnd Analytics shares are held by institutional investors. 36.9% of MYnd Analytics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
This is a breakdown of current ratings for Livongo Health and MYnd Analytics, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
MYnd Analytics has a consensus price target of $4.00, suggesting a potential downside of 26.74%. Given MYnd Analytics’ higher probable upside, analysts clearly believe MYnd Analytics is more favorable than Livongo Health.
This table compares Livongo Health and MYnd Analytics’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Earnings & Valuation
This table compares Livongo Health and MYnd Analytics’ gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|MYnd Analytics||$1.32 million||39.21||-$9.59 million||($1.86)||-2.94|
Livongo Health has higher earnings, but lower revenue than MYnd Analytics.
MYnd Analytics beats Livongo Health on 5 of the 8 factors compared between the two stocks.
About Livongo Health
Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications. Its products include Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company was formerly known as EosHealth, Inc. and changed its name to Livongo Health, Inc. in 2014. Livongo Health, Inc. was incorporated in 2008 and is headquartered in Mountain View, California.
About MYnd Analytics
MYnd Analytics, Inc. operates as a predictive analytics company primarily in the United States. The company manages the delivery of telepsychiatry and telebehavioral health services through a network of psychiatrists, psychologists, and therapists. The company is commercializing its psychiatric electroencephalogram (EEG) evaluation registry predictive analytics tool to help physicians reduce trial and error treatment in mental health. Its technology platform utilizes complex algorithms to analyze EEGs to generate psychiatric EEG evaluation registry reports to predict individual responses to a range of medications prescribed for the treatment of behavioral disorders, including depression, anxiety, bipolar disorder, post-traumatic stress disorder sand other non-psychotic disorders. The company was formerly known as CNS Response, Inc. and changed its name to MYnd Analytics, Inc. in November 2015. MYnd Analytics, Inc. was founded in 2000 and is headquartered in Mission Viejo, California.
Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.